GHK is a tripeptide naturally present in human plasma. Loren Pickart first isolated it in 1973 as the active fraction in old human serum that restored youthful gene expression in cultured hepatocytes. Bound to copper, GHK-Cu becomes a redox-active complex with measurable effects on collagen synthesis, angiogenesis, neurogenesis, and — the focus of this article — stem cell behaviour.
Four decades of research have produced more than 100 PubMed-indexed studies. The Pickart and Margolina 2017 paper in Cosmetics ("The Effect of the Human Peptide GHK on Gene Expression Relevant to Nervous System Function and Cognitive Decline") and its sister paper that same year on tissue remodelling are now the most-cited modern syntheses of the stem cell modulation data. UAE-based regenerative researchers regularly order GHK-Cu for in-vitro work modelling skin, hair, and wound-healing endpoints — and REVIVE LAB ships GHK-Cu next-day from Dubai stock to meet that demand.
Pickart's central thesis is that GHK-Cu acts as a "gene expression modulator" rather than a single-receptor agonist. Using Broad Institute Connectivity Map data, Pickart showed that GHK at 1 µM shifts the expression of approximately 31.2% of human genes — either upregulating tissue-protective and stem-cell-relevant transcripts or downregulating pro-inflammatory ones.
This breadth of pathway modulation is why GHK-Cu attracts attention from researchers studying tissue regeneration: it does not appear to push one biological lever, but to broadly nudge gene expression toward a "younger" phenotype.
Mesenchymal stem cells are the workhorse of regenerative research — they migrate to injury sites, differentiate into multiple connective tissue lineages, and secrete paracrine signals that recruit further repair cells. Several published studies have measured GHK-Cu's effect on MSC behaviour:
| Model | GHK-Cu concentration | Observed effect | Citation |
|---|---|---|---|
| Human bone marrow MSCs (in vitro) | 10–100 nM | Increased migration in scratch assay vs control | Kang 2009 |
| Rat skin wound model | Topical 5 mg/mL | Accelerated MSC infiltration into wound bed | Pickart 2015 |
| Human dermal fibroblasts & MSC co-culture | 1 µM | Upregulated decorin, collagen I, VEGF | Pickart 2017 |
| Cultured hair follicle papilla cells | 1 nM | Increased VEGF and hair shaft elongation | Pyo 2007 |
| Wound-healing diabetic mouse | SC 1 mg/kg | Improved closure rate vs vehicle | Arul 2007 |
The migration data is the most consistently replicated finding: across multiple labs, GHK-Cu at low nanomolar concentrations increases MSC chemotactic activity. The proposed mechanism is dual — direct upregulation of CXCR4 (a chemokine receptor on MSCs) and indirect recruitment via wounded-tissue VEGF and SDF-1 release.
The hair follicle is one of the most accessible adult stem cell niches in the body. Stem cells in the bulge region (HFSCs) cycle between quiescence and activation, driving the anagen-catagen-telogen hair cycle. GHK-Cu shows up repeatedly in the hair regeneration literature, and the mechanism appears to converge on the dermal papilla–HFSC axis.
Clinical human data is more limited than mechanism data, but small studies of copper peptide topicals (Awata 2019, Trueb 2018) showed measurable shaft diameter increases over 16–24 weeks. Pure injectable GHK-Cu research in humans is sparse — most published clinical work uses topical formulations.
For UAE researchers planning in-vitro or animal protocols, three implications follow from the published GHK-Cu literature:
For a deeper comparison of GHK-Cu against other regenerative tripeptides, see our BPC-157 tendon healing research overview. For UAE-specific reconstitution and storage notes, see the peptide fridge storage guide.
REVIVE supplies GHK-Cu as 50 mg and 100 mg lyophilised vials. Reconstitution choices depend on intended in-vitro working concentration:
| Vial | BAC water | Stock concentration | Typical in-vitro dilution |
|---|---|---|---|
| 50 mg | 5 mL | 10 mg/mL | 1:10,000 for 1 µM working |
| 50 mg | 10 mL | 5 mg/mL | 1:5,000 for 1 µM working |
| 100 mg | 10 mL | 10 mg/mL | 1:10,000 for 1 µM working |
| 100 mg | 5 mL | 20 mg/mL | For high-concentration topical research bases |
Reconstituted GHK-Cu should be refrigerated at 2–8°C and protected from light. The copper complex is reasonably stable but is sensitive to extended room-temperature exposure — a real consideration in UAE summer logistics, addressed in the section below.
REVIVE LAB operates from a Dubai warehouse with cold-chain logistics designed for the Gulf climate. Here is what same-day and 24h delivery looks like across the Emirates:
| Emirate | Delivery window | Cut-off | Cold-chain |
|---|---|---|---|
| Dubai | Same-day (4–6 hrs) | Order by 2 PM | Insulated phase-change pack |
| Abu Dhabi | Same-day or next-morning | Order by 12 PM | Insulated phase-change pack |
| Sharjah | Same-day (5–7 hrs) | Order by 1 PM | Insulated phase-change pack |
| Ajman | Same-day (6–8 hrs) | Order by 1 PM | Insulated phase-change pack |
| Ras Al Khaimah | Next-day | Order by 5 PM previous day | Insulated phase-change pack |
| Fujairah / UAQ | Next-day | Order by 5 PM previous day | Insulated phase-change pack |
For researchers comparing peptides across the regenerative category, our full UAE peptide catalogue lists all currently stocked SKUs with live availability.
Lyophilised GHK-Cu is stable at room temperature for several days, but the copper complex can develop trace oxidation if exposed repeatedly to high heat. REVIVE's phase-change packs hold internal box temperature below 25°C for 48 hours even at 45°C ambient — the worst-case Dubai August scenario. This is why same-day delivery from local Dubai stock is materially safer than international shipping, which can take 7–14 days through customs.
Honest summary: GHK-Cu's mechanism data is strong, its in-vitro stem cell modulation data is consistent, and its topical clinical signal is modest but real. However:
This is why GHK-Cu remains a research compound. The mechanism is interesting; the clinical proof is still being built.